Put Options

2 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2018

Apr 20, 2018

SELL
$83.06 - $100.98 $448,524 - $545,292
-5,400 Reduced 7.94%
62,600 $5.22 Million
Q4 2017

Jan 25, 2018

BUY
$93.56 - $116.6 $6.36 Million - $7.93 Million
68,000
68,000 $6.44 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16.1B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Jennison Associates LLC Portfolio

Follow Jennison Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jennison Associates LLC with notifications on news.